Melanoma & Skin Cancers

Quick Links
Commentary
News
Video
NewsMore ›

Fewer moles linked with more aggressive melanoma
NEW YORK – Consistent with another recently published report but counterintuitive, patients with a high number of nevi prior to developing a melanoma have more favorable... More »

Dr. Antonio Subtil

In skin lymphoma diagnosis, pathology must match clinical presentation
NEW YORK – Both dermatologists and pathologists can make the mistake of diagnosing a long list of pseudolymphomas as lymphomas, according to Dr. Antonio Subtil, who is an... More »

Ingenol mebutate helped clear actinic keratoses
Cryosurgery followed by topical ingenol mebutate cleared extensive regions of actinic keratosis, which helped reveal residual squamous cell carcinomas, according to a report... More »

CommentaryMore ›
Dr. Gideon Blumenthal

Immune-related patterns of response present challenges
With the race to develop cancer immunotherapies escalating and new agents appearing in the clinic, oncologists’ decision-making toolbox will need to evolve. “As... More »

Point/Counterpoint: What is the first-line treatment of choice for metastatic BRAF-mutant melanoma?
Dr. Mario Sznol and Dr. Jeffrey Sosman debate immunotherapy vs. BRAF-targeted therapy.

Mini X-Ray Device Treats Nonmelanoma Skin Cancers
MIAMI BEACH – An x-ray tube about the size of a sewing needle can safely deliver radiation to nonmelanoma skin tumors on the nose, scalp, or other highly visible areas of... More »

  VideoMore ›

VIDEO: Dual immunotherapy more powerful in melanoma, but where do we go from here?
CHICAGO – Combining the immunotherapy antibodies nivolumab and ipilimumab induced more robust responses in untreated advanced melanoma when used together than as single... More »

VIDEO: Lymphadenectomies don’t boost survival in melanoma with SLN micrometastases
CHICAGO – Complete lymph node dissection did not improve survival in a prospective, randomized trial of 483 patients with stage III melanoma and micrometastases in their... More »

VIDEO: Updating the immune response to nonmelanoma skin cancer
ASHEVILLE, N.C. – Recent advances in basic science have shown how the local immune environment in tissue surrounding nonmelanoma skin cancer compares to adjacent normal... More »